{
    "organizations": [],
    "uuid": "c0ece2bfef60e9e9f72b87355c7a8d9fd881dc3e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-dermapharm-holding-fy-ebitda-up-at/brief-dermapharm-holding-fy-ebitda-up-at-eur-112-9-million-idUSFWN1S402J",
    "ord_in_thread": 0,
    "title": "BRIEF-Dermapharm Holding FY EBITDA Up At EUR 112.9 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 27 (Reuters) - Dermapharm Holding SE:\n* REVENUE IS EXPECTED TO GROW BETWEEN 20-25% YEAR-ON-YEAR IN 2018 WITH ADJUSTED EBITDA UP 22-27%\n* REVENUE UP BY 5.1% TO EUR 467.1 MILLION IN FISCAL YEAR 2017 (PREVIOUS YEAR: EUR 444.5 MILLION)\n* FY EBITDA AMOUNTED TO EUR 112.9 MILLION (PREVIOUS YEAR: EUR 102.7 MILLION) Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-27T13:38:00.000+03:00",
    "crawled": "2018-04-28T12:54:52.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "dermapharm",
        "holding",
        "se",
        "revenue",
        "expected",
        "grow",
        "adjusted",
        "ebitda",
        "revenue",
        "eur",
        "million",
        "fiscal",
        "year",
        "previous",
        "year",
        "eur",
        "million",
        "fy",
        "ebitda",
        "amounted",
        "eur",
        "million",
        "previous",
        "year",
        "eur",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}